BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10590684)

  • 1. [Detection of K-ras mutations in colon cancer by PHA-PHFA (preferential homoduplex formation assay)].
    Funato T; Zeng Z; Satoh J; Fujiwara J; Kaku M; Sasaki T
    Rinsho Byori; 1999 Nov; 47(11):1059-63. PubMed ID: 10590684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of mutations in the CFTR gene using the PCR-dependent preferential homoduplex formation assay (PCR-PHFA) system].
    Oka T; Nakano H; Yamane A
    Nihon Rinsho; 1996 Feb; 54(2):518-24. PubMed ID: 8838108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors.
    Khanna M; Park P; Zirvi M; Cao W; Picon A; Day J; Paty P; Barany F
    Oncogene; 1999 Jan; 18(1):27-38. PubMed ID: 9926917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic alterations of human colorectal cancer].
    Suzuki T; Ishioka C; Gamo M; Niitani T; Shimodaira H; Kanbe M; Yamazaki T; Yusa Y; Kanamaru R
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):343-50. PubMed ID: 8109990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissue.
    Huang J; Kirk B; Favis R; Soussi T; Paty P; Cao W; Barany F
    Oncogene; 2002 Mar; 21(12):1909-21. PubMed ID: 11896624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
    Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
    Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of K-RAS mutation detection in colorectal cancer and in surgical margins of the colon.
    Okulczyk B; Kovalchuk O; Piotrowski Z; Myśliwiec P; Chyczewski L
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():52-4. PubMed ID: 15638373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of K-ras point mutation by enriched PCR-colorimetric plate assay.
    Santiago FS; Todd AV; Hawkins NJ; Ward RL
    Mol Cell Probes; 1997 Feb; 11(1):33-8. PubMed ID: 9076712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive detection through REMS-PCR technique of K-ras mutations in stool DNA of patients with colorectal cancer.
    Mixich F; Ioana M; Voinea F; Săftoiu A; Ciurea T
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):5-10. PubMed ID: 17410282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
    Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay design and optimization of mutant-enriched PCR based method for detection of K-ras gene mutations in pancreatic carcinoma.
    Ugorcáková J; Hlavatý T; Babál P; Janega P; Bukovská G; Halgasová N; Hlavatá A; Timko J; Duris I
    Neoplasma; 2006; 53(5):363-71. PubMed ID: 17013530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes.
    Wabuyele MB; Farquar H; Stryjewski W; Hammer RP; Soper SA; Cheng YW; Barany F
    J Am Chem Soc; 2003 Jun; 125(23):6937-45. PubMed ID: 12783546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sampling method as a key factor in identifying K-ras oncogene mutations in preneoplastic colorectal lesions.
    Ronai Z; Minamoto T; Butler R; Tobi M; Luo FQ; Zang E; Esumi H; Sugimura T
    Cancer Detect Prev; 1995; 19(6):512-7. PubMed ID: 8925520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
    Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
    Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.
    Petrowsky H; Sturm I; Graubitz O; Kooby DA; Staib-Sebler E; Gog C; Köhne CH; Hillebrand T; Daniel PT; Fong Y; Lorenz M
    Eur J Surg Oncol; 2001 Feb; 27(1):80-7. PubMed ID: 11237496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping of K-ras codons 12 and 13 mutations in colorectal cancer by capillary electrophoresis.
    Chen YL; Chang YS; Chang JG; Wu SM
    J Chromatogr A; 2009 Jun; 1216(26):5147-54. PubMed ID: 19450806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.